Natera SG&A Expenses 2014-2025 | NTRA
Natera annual/quarterly sg&a expenses history and growth rate from 2014 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Natera sg&a expenses for the quarter ending March 31, 2025 were $0.267B, a 37.36% increase year-over-year.
- Natera sg&a expenses for the twelve months ending March 31, 2025 were $0.914B, a 37.85% increase year-over-year.
- Natera annual sg&a expenses for 2024 were $0.841B, a 36.07% increase from 2023.
- Natera annual sg&a expenses for 2023 were $0.618B, a 5.05% increase from 2022.
- Natera annual sg&a expenses for 2022 were $0.589B, a 15.18% increase from 2021.
| Natera Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $841 |
| 2023 | $618 |
| 2022 | $589 |
| 2021 | $511 |
| 2020 | $304 |
| 2019 | $206 |
| 2018 | $155 |
| 2017 | $155 |
| 2016 | $136 |
| 2015 | $110 |
| 2014 | $63 |
| 2013 | $32 |
| Natera Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $267 |
| 2024-12-31 | $235 |
| 2024-09-30 | $214 |
| 2024-06-30 | $198 |
| 2024-03-31 | $194 |
| 2023-12-31 | $161 |
| 2023-09-30 | $155 |
| 2023-06-30 | $153 |
| 2023-03-31 | $150 |
| 2022-12-31 | $144 |
| 2022-09-30 | $148 |
| 2022-06-30 | $149 |
| 2022-03-31 | $148 |
| 2021-12-31 | $147 |
| 2021-09-30 | $128 |
| 2021-06-30 | $127 |
| 2021-03-31 | $108 |
| 2020-12-31 | $94 |
| 2020-09-30 | $76 |
| 2020-06-30 | $68 |
| 2020-03-31 | $66 |
| 2019-12-31 | $59 |
| 2019-09-30 | $57 |
| 2019-06-30 | $47 |
| 2019-03-31 | $44 |
| 2018-12-31 | $41 |
| 2018-09-30 | $38 |
| 2018-06-30 | $37 |
| 2018-03-31 | $38 |
| 2017-12-31 | $49 |
| 2017-09-30 | $34 |
| 2017-06-30 | $34 |
| 2017-03-31 | $38 |
| 2016-12-31 | $38 |
| 2016-09-30 | $35 |
| 2016-06-30 | $33 |
| 2016-03-31 | $30 |
| 2015-12-31 | $30 |
| 2015-09-30 | $28 |
| 2015-06-30 | $28 |
| 2015-03-31 | $23 |
| 2014-12-31 | |
| 2014-09-30 | $16 |
| 2014-06-30 | $14 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $18.251B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.177B | 26.18 |
| CVS Health (CVS) | United States | $78.558B | 9.80 |
| Elevance Health (ELV) | United States | $63.743B | 8.57 |
| Cencora (COR) | United States | $55.449B | 19.29 |
| DiDi Global (DIDIY) | China | $23.674B | 25.15 |
| Labcorp Holdings (LH) | United States | $21.769B | 17.18 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.562B | 0.00 |
| ICON (ICLR) | Ireland | $13.663B | 13.15 |
| CochLear (CHEOY) | Australia | $13.429B | 0.00 |
| Solventum (SOLV) | United States | $12.346B | 13.07 |
| Medpace Holdings (MEDP) | United States | $12.001B | 31.76 |
| Revvity (RVTY) | United States | $10.361B | 17.98 |
| Viatris (VTRS) | United States | $10.258B | 3.52 |
| Avantor (AVTR) | United States | $9.158B | 13.31 |
| Sonic Healthcare (SKHHY) | Australia | $8.783B | 0.00 |
| HealthEquity (HQY) | United States | $8.388B | 36.74 |
| Charles River Laboratories (CRL) | United States | $8.332B | 16.33 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.144B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.822B | 32.45 |
| Amplifon S.p.A (AMFPF) | Italy | $3.915B | 21.43 |
| BrightSpring Health Services (BTSG) | United States | $3.630B | 33.31 |
| Sotera Health (SHC) | United States | $3.262B | 18.53 |
| GeneDx Holdings (WGS) | United States | $2.909B | 67.07 |
| Surgery Partners (SGRY) | United States | $2.813B | 36.58 |
| Alignment Healthcare (ALHC) | United States | $2.729B | 0.00 |
| Concentras Parent (CON) | United States | $2.560B | 14.79 |
| Organon (OGN) | United States | $2.522B | 2.68 |
| Progyny (PGNY) | United States | $2.015B | 44.36 |
| Premier (PINC) | United States | $1.769B | 13.43 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 34.21 |
| PACS (PACS) | United States | $1.686B | 0.00 |
| Ardent Health (ARDT) | United States | $1.516B | 6.46 |
| Teladoc Health (TDOC) | United States | $1.274B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.213B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.052B | 8.01 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.741B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.702B | 6.57 |
| CareDx (CDNA) | United States | $0.684B | 10.68 |
| Embecta (EMBC) | United States | $0.594B | 4.00 |
| LifeMD (LFMD) | United States | $0.473B | 0.00 |
| Nutex Health (NUTX) | United States | $0.471B | 7.13 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.48 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| So-Young (SY) | China | $0.451B | 0.00 |
| Omada Health (OMDA) | $0.451B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.449B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.448B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.407B | 0.00 |
| Enhabit (EHAB) | United States | $0.340B | 28.00 |
| Oncology Institute (TOI) | United States | $0.327B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.278B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| Sera Prognostics (SERA) | United States | $0.105B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| KindlyMD (NAKA) | United States | $0.053B | 0.00 |
| Biodesix (BDSX) | United States | $0.052B | 0.00 |
| ModivCare (MODV) | United States | $0.041B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |